butalamine

Also Known As:

Adrevil; LA 1221; Surheme; butalamine hydrochloride; N,N-dibutyl-N'-(3-phenyl-1,2,4-oxadiazol-5-yl)-1,2-ethanediamine

Networked: 7 relevant articles (0 outcomes, 1 trials/studies)

1.	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/01/1973 - "[Clinical and thermometric study of Surheme in 30 cases of cerebrovascular disorders]."
2.	Vertigo (Positional Vertigo) 01/01/1976 - "[Surheme (Butalamine) in the treatment of vertigo]."
3.	Labyrinth Diseases 05/01/1976 - "[Test of butalamine in labyrinth diseases]."
4.	Deafness (Deaf Mutism) 07/01/1976 - "[Clinical investigation into the action of surheme in perception deafness]."
5.	Arteritis 10/31/1979 - "[Prolonged treatment of obliterantive arteritis with butalamine. "

1.	Drug Therapy (Chemotherapy)